Cumberland Pharmaceuticals (CPIX) Other financing activities (2010 - 2022)

Cumberland Pharmaceuticals has disclosed Other financing activities across 13 years of filings, most recently posting -$370464.0 for Q1 2022.

• Other financing activities for Q1 2022 came in at -$370464.0, down 232.3% year-over-year; the trailing twelve-month figure through Mar 2022 was -$650484.0 (down 147.35% YoY), and the FY2018 annual result was $81886.0, down 10.12% from the prior year.
• Other financing activities came in at -$370464.0 for Q1 2022 at Cumberland Pharmaceuticals, up from -$632646.0 in the prior quarter.
• In the past five years, Other financing activities ranged from a high of $1.0 million in Q3 2019 to a low of -$806390.0 in Q4 2020.
• The 5-year median for Other financing activities is $92225.5 (2018), against an average of $8021.5.
• Across the five-year window, Other financing activities slumped 1435.98% in 2020 and surged 181.39% in 2021, its largest moves.
• Cumberland Pharmaceuticals' Other financing activities stood at $81886.0 in 2018, then tumbled by 164.11% to -$52500.0 in 2019, then plunged by 1435.98% to -$806390.0 in 2020, then climbed by 21.55% to -$632646.0 in 2021, then soared by 41.44% to -$370464.0 in 2022.
• The last three Other financing activities figures came in at -$370464.0 (Q1 2022), -$632646.0 (Q4 2021), and $452536.0 (Q3 2021), per Business Quant data.